Rs4919510 in hsa-mir-608 is associated with outcome but not risk of colorectal cancer

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Ryan, Bríd M ^a   McClary, Andrew C ^a,b   Valeri, Nicola ^c   Robinson, Dillon ^a   Paone, Alessio ^c   Bowman, Elise D ^a   Robles, Ana I ^a   Croce, Carlo ^c   Harris, Curtis C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 608; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CASE CONTROL STUDY; CAUCASIAN; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GENOTYPING TECHNIQUE; HUMAN; MAJOR CLINICAL STUDY; MALE; RACE DIFFERENCE; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; COLORECTAL TUMOR; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MUTATION; ONCOGENE RAS; PROGNOSIS; RISK FACTOR; UNITED STATES;

AFRICAN AMERICANS; AGED; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENES, RAS; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICRORNAS; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; UNITED STATES;

EID: 84861002252     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036306     Document Type: Article

References (31)

1. Siegel R, Ward E, Brawley O, Jemal A, (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236.
2. Alexander DD, Waterbor J, Hughes T, Funkhouser E, Grizzle W, et al. (2007) African-American and Caucasian disparities in colorectal cancer mortality and survival by data source: an epidemiologic review. Cancer Biomark 3: 301-313.
3. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
4. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ, (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140-144.
5. Guo H, Ingolia NT, Weissman JS, Bartel DP, (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466: 835-840.
6. Thai TH, Christiansen PA, Tsokos GC, (2010) Is there a link between dysregulated miRNA expression and disease? Discov Med 10: 184-194.
7. Iorio MV, Croce CM, (2009) MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 27: 5848-5856.
8. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, et al. (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299: 425-436.
9. Landi D, Gemignani F, Naccarati A, Pardini B, Vodicka P, et al. (2008) Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis 29: 579-584.
10. Boni V, Zarate R, Villa JC, Bandres E, Gomez MA, et al. (2010) Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan. Pharmacogenomics J.
11. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103: 2257-2261.
12. Ryan BM, Robles AI, Harris CC, (2010) Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 10: 389-402.
13. Quach H, Barreiro LB, Laval G, Zidane N, Patin E, et al. (2009) Signatures of purifying and local positive selection in human miRNAs. Am J Hum Genet 84: 316-327.
14. Yu Z, Li Z, Jolicoeur N, Zhang L, Fortin Y, et al. (2007) Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers. Nucleic Acids Res 35: 4535-4541.
15. Bashyam MD, Bair R, Kim YH, Wang P, Hernandez-Boussard T, et al. (2005) Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer. Neoplasia 7: 556-562.
16. Daido S, Takao S, Tamiya T, Ono Y, Terada K, et al. (2004) Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions. Oncol Rep 12: 789-795.
17. Kim JH, Dhanasekaran SM, Mehra R, Tomlins SA, Gu W, et al. (2007) Integrative analysis of genomic aberrations associated with prostate cancer progression. Cancer Res 67: 8229-8239.
18. Zheng HT, Peng ZH, Zhou CZ, Wang ZW, Qiu GQ, et al. (2005) [Refined mapping of loss of heterzygosity on 10q23-24 in sporadic colorectal carcinoma]. Zhonghua Yi Xue Za Zhi 85: 2124-2127.
19. Wang X, Zbou C, Qiu G, Fan J, Tang H, et al. (2008) Screening of new tumor suppressor genes in sporadic colorectal cancer patients. Hepatogastroenterology 55: 2039-2044.
20. Goodman JE, Bowman ED, Chanock SJ, Alberg AJ, Harris CC, (2004) Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk. Carcinogenesis 25: 2467-2472.
21. Hess KR, (1995) Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. Stat Med 14: 1707-1723.
22. Mafra L, Santos SM, Siegel R, Alves I, Paz FA, et al. (2012) Packing interactions in hydrated and anhydrous forms of the antibiotic Ciprofloxacin: a solid-state NMR, X-ray diffraction, and computer simulation study. J Am Chem Soc 134: 71-74.
23. Thorisson GA, Smith AV, Krishnan L, Stein LD, (2005) The International HapMap Project Web site. Genome Res 15: 1592-1593.
24. Zanetti KA, Haznadar M, Welsh JA, Robles AI, Ryan BM, et al. (2012) 3′-UTR and Functional Secretor Haplotypes in Mannose-Binding Lectin 2 Are Associated with Increased Colon Cancer Risk in African Americans. Cancer Res 72: 1467-1477.
25. Xing JL, Wan S, Zhou F, Qu F, Li B, et al. (2011) Genetic polymorphisms in pre-microRNA genes as prognostic markers of colorectal cancer. Cancer Epidemiol Biomarkers Prev.
26. Kawahara Y, Zinshteyn B, Sethupathy P, Iizasa H, Hatzigeorgiou AG, et al. (2007) Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science 315: 1137-1140.
27. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, et al. (2008) Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A 105: 7269-7274.
28. Mishra PJ, Humeniuk R, Longo-Sorbello GS, Banerjee D, Bertino JR, (2007) A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Proc Natl Acad Sci U S A 104: 13513-13518.
29. Sanoff HK, Sargent DJ, Green EM, McLeod HL, Goldberg RM, (2009) Racial differences in advanced colorectal cancer outcomes and pharmacogenetics: a subgroup analysis of a large randomized clinical trial. J Clin Oncol 27: 4109-4115.
30. Ji D, Deeds SL, Weinstein EJ, (2007) A screen of shRNAs targeting tumor suppressor genes to identify factors involved in A549 paclitaxel sensitivity. Oncol Rep 18: 1499-1505.
31. Kim JM, Song JS, Cho HH, Shin KK, Bae YC, et al. (2011) Effect of the modulation of leucine zipper tumor suppressor 2 expression on proliferation of various cancer cells functions as a tumor suppressor. Mol Cell Biochem 346: 125-136.